MSB 7.69% $1.19 mesoblast limited

Totally agree here the latest safety report for CHF trial...

  1. 349 Posts.
    lightbulb Created with Sketch. 7
    Totally agree here the latest safety report for CHF trial recommended continuing the trial.No safety concerns after 27 months into this trial and also all of the other current trials underway.The term used (very high risk) is an over exageration in the area of safety and even in relation to current advanced phase 3 trials!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.